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ABSTRACT: Macrocyclic triamine disulfonamides can be
synthesized by double Tsuji−Trost N-allylation reaction of
open-chain disulfonamides with 2-alkylidene-1,3-propanediyl
bis(carbonates). The previously used Atkins−Richman macro-
cyclization method generally gives lower yields and requires
more tedious puriﬁcation of the product. Solvent, palladium
source, ligand, and concentration have all been varied to
optimize the yields of two key 12-membered ring bioactive
compounds, CADA and VGD020. The new approach tolerates a wide range of functional groups and gives highest yields for
symmetrical compounds in which the acidities of the two sulfonamide groups are matched, although the yields of unsymmetrical
compounds are still generally good. The method has also been extended to the synthesis of 11-membered rings, pyridine-fused
macrocycles, and products bearing an ester or aryl substituent on the exocyclic double bond.
■ INTRODUCTION
Macrocyclic polyamines, which are of interest for their
biological activity,1 as receptors for anions, or as ligands for
transition metals, can be synthesized by a number of methods.2
Among the most common is the Atkins−Richman procedure
involving reaction of the dianion of an open-chain ditosylamide
with the disulfonate ester of an open-chain diol.3,4 This
approach has also been modiﬁed to accommodate other
dinucleophiles and dielectrophiles, including dihalides.5−8 As
shown in Scheme 1 (method A), a modiﬁed Atkins−Richman
approach was used in the synthesis of 3-methylene-1,5,9-
triazacyclododecane disulfonamides, which are of interest as
potential immunomodulatory and antiviral drugs.9−13 Many
analogs have been synthesized by this method, but it requires
slow addition, large volumes of solvent, and tedious
puriﬁcation to remove oligomeric byproducts.
The exocyclic double bond in the 3-position of the 1,5,9-
triazacyclododecane ring, which is important for activity,9
enables an alternate macrocyclization strategy involving double
N-allylation, as shown in Scheme 1 (method B). Tsuji−
Trost14−16 N-allylation is well-precedented,17−25 and hydroxyl
groups in erythromycin A and other macrolide antibiotics have
been bridged with an isobutylene unit by palladium-catalyzed
reaction with 3-methylene-1,3-propanediyl bis(t-butylcarbon-
ate) in THF or toluene.26−28 In addition, palladium-catalyzed
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Scheme 1. Atkins−Richman (A) and Tsuji−Trost (B)
Approaches to 3-Methylene-1,5,9-triazacyclododecanes
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C-allylation with similar dielectrophiles has been used in
natural product total syntheses.29,30
■ RESULTS AND DISCUSSION
The proposed Pd-catalyzed macrocyclization reaction was ﬁrst
tested on the synthesis of the lead compound, cyclo-
triazadisulfonamide, CADA (2), which can be prepared in
54% yield by the Atkins−Richman method.10 As shown in
Table 1, various solvents were tried and acetonitrile gave the
best yield (95%). No oligomeric side products were detected,
and the pure HCl salt was obtained by simply treating the
crude product with methanolic HCl, evaporating, and
triturating the residue with hexane. Three bis(electrophiles)
were tested: 1,3-dichloro-2-methylenepropane, 2-methylene-
1,3-propanediyl diacetate, and 2-methylene-1,3-propanediyl
bis(t-butylcarbonate). Only the last, a carbonate ester, gave
the desired product.
Macrocyclization results for symmetrical CADA analogs are
also shown in Table 1. Bis(4-methoxybenzenesulfonyl) analog
410 was also obtained in 95% yield from reaction in acetonitrile
and in lower yield from that in THF. An attempt to prepare 4
from the HCl salt of the precursor disulfonamide (3) gave no
reaction. Removal of the benzyl tail group also gave nearly
quantitative macrocyclization for 6. This is signiﬁcant because
the Atkins−Richman approach did not work in attempts to
prepare 6, which was prepared previously by debenzylation of
2. Cyano groups in 11 did not interfere with the reaction, and
dibrosyl (8)10 and dinosyl (10)10 analogs were obtained in
similar yields.
Pd-catalyzed macrocyclization was also tested on synthesis
of unsymmetrical 3-methylene-1,5,9-triazacyclododecanes
bearing two diﬀerent arenesulfonyl side arms (Table 2). Yields
obtained were generally somewhat lower than those for the
symmetrical analogs, probably because of two factors: diﬀerent
acidities of arenesulfonyl side arms could lead to enhanced
formation of oligomeric byproducts (see below), and these
unsymmetrical analogs could not be puriﬁed as solids. The
results do show compatibility with additional functional
groups, such as in the chloro (18),11 dimethylamino (26, 28,
44, 46, and 50),10,11 and nitro (36, 38, and 40)11 analogs. In
the case of resynthesis of 4-(dimethylamino)naphthalene-1-
sulfonyl (dansyl) analog 28,10 the disulfonamide precursor
(27) was prepared by a more expedient route to unsym-
metrical compounds11 that was developed after the original
synthesis of 28.10
The expectation that byproducts may be formed when the
two arenesulfonamide groups are diﬀerent is apparent from the
catalytic cycle shown in Figure 1. Electron-donating or
electron-withdrawing substituents on benzenesulfonamides
aﬀect the pKa of the NH group. The catalytic cycle shows
that formation of the π-allyl intermediate generates an
alkoxide, which serves as the base sulfonamide. For an
unsymmetrical open-chain disulfonamide, the more acidic
NH should be selectively allylated. The intermediate must then
be deprotonated on the less acidic NH to undergo macro-
cyclization by intramolecular N-allylation, so intermolecular
reaction with the more acidic NH of a second open-chain
disulfonamide molecule may compete. An oligomer resulting
from this eﬀect is shown later in Scheme 2.
An attempt was made to extend the scope of this reaction to
macrocycles containing an ether linkage. The result shown in
Scheme 2 was formation of the 2+1 oligomer 52 (VGD043),
which was obtained in 27% yield after column chromatog-
raphy. Preferential reaction of the sulfonamide nitrogen
relative to the hydroxyl oxygen is consistent with the greater
acidity of benzenesulfonamide relative to methanol (pKa 16.1
vs 29.0, respectively, in DMSO).31 Similar products have been
detected spectroscopically as byproducts from reactions of
some unsymmetrical disulfonamides.
Analog 54 (VGD020)11 is one of the more biologically
potent compounds prepared to date, so attempts were made to
improve its synthesis. As shown in Table 3, omission of sodium
carbonate from the reaction mixture gave variable results, so
0.1−1.0 molar equivalents were included in subsequent
reactions to insure complete deprotonation of the tertiary
nitrogen. This resulted in high yields with three diﬀerent Pd
catalysts, Pd2dba3, Pd(OAc)2, and Pd(PPh3)4. As shown in
Table 1, when the HCl salt of disulfonamide 3 was used in the
Table 1. Pd-Catalyzed Synthesis of Symmetrical 3-Methylene-1,5-diarenesulfonyl-1,5,9-triazacyclododecanesa
starting material R1 R2 X solvent product yield
1 Me Bn OBoc MeOH 2 (CADA·HCl)b 53%
1 Me Bn OBoc THF 2 (CADA·HCl)b 73%
1 Me Bn OBoc MeCN 2 (CADA·HCl)b 95%
1 Me Bn Cl MeCN 2 (CADA·HCl)b 0%
1 Me Bn OAc MeCN 2 (CADA·HCl)b 0%
3 OMe Bn OBoc THF 4 (KKD023·HCl)b 65%
3 OMe Bn OBoc MeCN 4 (KKD023·HCl)b 85%
3 OMe Bn OBoc MeCN no reactionc
5 Me H OBoc MeCN 6 (94-129·HCl)b 98%
7 Br Bn OBoc MeCN 8 (ASPB127)b 52%
9 NO2 Bn OBoc MeCN 10 (AS114)
b,d 56%
11 CN Bn OBoc MeCN 12 (ES03) 47%e
aReaction conditions (unless indicated otherwise): 15−25 mM disulfonamide in anhydrous solvent, 2−2.5 equiv dicarbonate ester, 3 mol %
Pd2(dba)3, and 6 mol % dppb, stirred under reﬂux for 18−24 h.
bRef 10; HCl salts were formed by treatment of the crude product with methanolic
HCl and evaporation. cThe HCl salt of the disulfonamide was used. d9 mM disulfonamide; 5 equiv dicarbonate ester. eOverall yield for two steps,
including synthesis of 11.
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attempted reaction, no product (4) was obtained. Tertiary
amines can become partially protonated and form bicarbonate
salts when exposed to water and atmospheric carbon dioxide.
The added Na2CO3 apparently scavenges protons that can
quench the N-allylation reaction by protonating t-butoxide,
which is needed for sulfonamide deprotonation (see catalytic
cycle in Figure 1).
With Pd2dba3 as a source of Pd, reactions failed when a
phosphine ligand was omitted. While reactions worked with
triphenylphosphine and dppf as ligands, somewhat lower yields
were observed. Other sources of Pd such as Pd(PPh3)4 and
Pd(OAc)2 can also be used, although Pd2dba3 gave the highest
yield. When the bis(electrophile) 2-methylene-1,3-propanediyl
bis(t-butylcarbonate) was replaced with 2-methylene-1,3-
propanediyl bis(methylcarbonate), the reaction succeeded in
good yields. This is signiﬁcant for large-scale reactions, because
the bis(methylcarbonate) reagent is less expensive to prepare
than the diBoc compound. When the concentration of the
reagents and catalyst were decreased from 15 to 20 mM by
about half (9 mM), the yield almost doubled. The last entry in
Table 3 shows that greater dilution did not improve the yield
further. Slow addition of mixtures of the two reactants to hot
solvent containing the catalyst was also attempted but did not
improve the yield.
Hydroxyl is considered a diﬃcult leaving group in Tsuji−
Trost chemistry,15 although allylic alcohols have been used for
N-allylations under certain conditions.32−35 Because of its
lower cost and our need to prepare 54 on a larger scale, we also
attempted macrocyclization with 2-methylene-1,3-propanediol
under conditions used with dicarbonates, but no product (54)
was isolated.
Table 2. Pd-Catalyzed Synthesis of Unsymmetrical 3-
Methylene-1,5-diarenesulfonyl-1,5,9-triazacyclododecanesa
starting
material Ar1 Ar2 R2 product yield
13 p-tolyl Ph CH2C6H11 14 (VGD025)
b 37%
15 p-tolyl 4-tBuPh CH2C6H11 16 (VGD017)
b 53%
17 p-tolyl 4-ClPh CH2C6H11 18
(VGD018·HCl)b
27%
19 p-tolyl 1-
naphthyl
CH2C6H11 20
(VGD021·HCl)b
38%
21 p-tolyl 2-
naphthyl
CH2C6H11 22 (VGD022)
b 37%
23 p-tolyl 5-isoquin. CH2C6H11 24 (VGD019)
b 38%
25 danc 4-MeOPh CH2C6H11 26
(VGD029·HCl)b
46%
27 danc p-tolyl CH2C6H11 28
(KKD016·HCl)d
56%
29 p-tolyl 4-Ac CH2C6H11 30 (DJ005)
e 28%
31 p-tolyl 4-CN CH2C6H11 32 (DJ002)
e 36%
33 p-tolyl 4-MeOPh Bn 34
(VGD027·HCl)b
56%
35 p-tolyl 4-NO2Ph Bn 36 (CK032)
e,f 32%
37 p-tolyl 3-NO2Ph Bn 38 (CK116)
e,f 39%
39 p-tolyl 2-NO2Ph Bn 40 (CK037)
e,f 43%
41 p-tolyl 4-CF3OPh Bn 42 (CK043)
e,f 41%
43 p-tolyl 4-
NMe2Ph
Bn 44 (CK078)e,f 40%
45 p-tolyl 3-
NMe2Ph
Bn 46 (CK207)e,f 57%
47 p-tolyl 4-FPh Bn 48
(CK201·HCl)e,f
47%
49 p-tolyl NMe2 Bn 50 (CK195)
e,f 42%
aReaction conditions: 15−20 mM disulfonamide in anhydrous
acetonitrile, 2.5 equiv dicarbonate ester, 3 mol % Pd2(dba)3, 6 mol
% dppb, stirred under reﬂux for 18−24 h. bRef 11. c5-Dimethylamino-
1-naphthyl. dRef 10. e0.1−0.5 equiv Na2CO3 was added to the
reaction mixture. fRef 13.
Figure 1. Catalytic cycle for palladium-catalyzed N-allylation of
sulfonamides with allylic carbonates.
Scheme 2. Attempted Macrocyclization of a
Hydroxytosylate, Resulting in Oligomerization to 52
Table 3. Yield Optimization for Synthesis of VGD020 (54)a
catalyst (equiv) ligand (equiv) base (equiv) R yield (%)
Pd2dba3 (0.03) dppb (0.06) none tBu variable
Pd2dba3 (0.03) dppb (0.06) Na2CO3 (0.1) tBu 25−26
Pd2dba3 (0.03) dppb (0.06) Na2CO3 (1.0) tBu 25−26
Pd(OAc)2 (0.03) dppb (0.06) Na2CO3 (1.0) tBu 20
Pd(PPh3)4 (0.06) dppb (0.06) Na2CO3 (1.0) tBu 10
Pd2dba3 (0.03) none Na2CO3 (1.0) tBu 0
Pd2dba3 (0.03) PPh3 (0.06) Na2CO3 (1.0) tBu 20
Pd2dba3 (0.03) dppf (0.06) Na2CO3 (1.0) tBu 9
Pd2dba3 (0.03) dppb (0.06) Na2CO3 (1.0) Me 40
Pd2dba3 (0.03) dppb (0.06) Na2CO3 (1.0) tBu 50−56b
Pd2dba3 (0.03) dppb (0.06) Na2CO3 (1.0) tBu 48
c
aReaction conditions (unless indicated otherwise): 15−20 mM
disulfonamide in anhydrous acetonitrile, stirred under reﬂux for
18−24 h. b9 mM disulfonamide. c4 mM disulfonamide.
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Other variations attempted were to change the size of the
macrocyclic ring and to fuse a pyridine ring in the position of
the tertiary nitrogen bearing the tail group (Scheme 3).
Compound 56 (ES-US5) with an 11-membered macrocyclic
ring was successfully isolated in modest yield (37%), and
compound 58 (SH28) consisting of a 12-membered macro-
cycle fused to pyridine was prepared in 56% yield. An attempt
to carry out an analogous cyclization to form a 10-membered
ring failed, but after adjusting the reaction conditions, the 20-
membered 2+2 macrocycle 60 (LAL012) was isolated in 50%
yield.
Further experiments were conducted to determine if
substituents on the isobutylene head group could be tolerated
(Scheme 4). Use of diBoc reagents with an ester or a phenyl
substituent gave the macrocyclic products in modest yield.
Ester 62 (RA014) was isolated as a 1:1 mixture of E/Z
stereoisomers that could not be separated by chromatography,
but recrystallization gave a crystalline 1.4:1 mixture that
yielded to full characterization, including combustion micro-
analysis. Attempts to prepare an analog with two methyl
substituents on the exocyclic double bond failed to give the 12-
membered macrocycle. Chromatography of the reaction
mixture gave bis(diene) 64 (TL002) instead. This side
product was initially identiﬁed by mass spectrometry, then
the diBoc reagent was used in larger excess, and 64 was
isolated in 88% yield. The formation of this open-chain
bis(diene) can be attributed to steric hindrance of macro-
cyclization and base-mediated E2′ elimination of the allylic
BocO− group of the monoallylated intermediate (cf. Figure 1).
The successful macrocyclization of 1 with the phenyl-
substituted di(Boc) reagent 65 to form 66 with an exocylic
benzylidine substituent in the head group is also shown in
Scheme 4.
■ CONCLUSIONS
We conclude that Pd-catalyzed reaction of disulfonamides with
doubly allylic bis(carbonates) is a versatile approach to useful
macrocyclic polyamines that give good yields, when compared
with other macrocyclization methods. The reaction tolerates a
wide range of substituents and can be used to prepare 11-
membered rings and pyridine-fused analogs, as well as
macrocyclic triamines with monosubstituted isobutylene head
groups.
■ EXPERIMENTAL SECTION
General Methods. All reactions were performed under
anhydrous nitrogen. Solvents and reagents obtained from
Sigma-Aldrich Chemical Company or Fisher Scientiﬁc were of
ACS reagent grade or better. They were used without
puriﬁcation, unless stated otherwise. HCl (2 N) solutions in
methanol/water were made from 42 mL of concentrated aq.
HCl (12.1 N) and 210 mL of methanolic HCl salts were
triturated by sonication in anhydrous diethyl ether (5−15 mL,
unless stated otherwise) for 5 min and ﬁltration, repeating the
process at least twice. “Overnight” periods are approximately
16 h. Organic solutions were dried over anhydrous Na2SO4
and then ﬁltered. Drying in vacuo was done at 0.1 mm and at
room temperature, unless stated otherwise. Column chroma-
tography employed Sorbent Technologies neutral alumina
(50−200 μm) or standard grade silica (32−63 μm), unless
stated otherwise. Melting points were measured with Thomas-
Hoover or Mel-Temp apparatus and are uncorrected. 1H NMR
(400 or 500 MHz) and 13C NMR (100 or 125 MHz) spectra
were acquired on Varian 400 or Varian Unity+ 500
spectrometers. Chemical shifts (δ) are reported in ppm values
relative to solvent peaks as follows: 1H, CDCl3/TMS = 0.00,
DMSO-d6 = 2.50, CD3OD = 3.31;
13C, CDCl3 = 77.23,
DMSO-d6 = 39.7, CD3OD = 49.15 ppm. Infrared spectra (IR)
were acquired on a Nicolet 6700 FTIR spectrometer. Low-
resolution mass spectra (MS) were recorded on a Waters
Micromass ZQ electrospray ionization quadrupole mass
spectrometer employing positive-ion detection (cap. voltage
= 3.5 kV). High-resolution mass spectra (HRMS) were
obtained on an Agilent 6230 TOF mass spectrometer.
Combustion analysis samples were dried at 78 °C (0.1 mm,
2 d), unless noted otherwise, and microanalysis was done by
NuMega Resonance Labs, Inc. After puriﬁcation, all products
were at least 95% pure, as proven by C,H,N microanalysis or
NMR spectroscopy.
Scheme 3. Ring Size and Pyridine Ring Fusion Variations
Scheme 4. Head Group Variations
ACS Omega Article
DOI: 10.1021/acsomega.8b02555
ACS Omega 2019, 4, 1254−1264
1257
General Procedure for Tsuji−Trost Macrocyclization
Synthesis of 2, 4, 6, 8, 10, and 28. All glassware and
equipment used in macrocyclization reactions, including stir
bars, spatulas, syringes, and needles, were dried overnight at
110 °C. Anhydrous acetonitrile (AN) used in macrocycliza-
tions was dried by distillation from CaH2. All reagents were
dried at 0.1 mm overnight before use.
In a 250 mL ﬂask equipped with an inlet for N2 and a
stirring bar, a mixture of 1.9 mmol of the disulfonamide, 4.7
mmol of the bis(electrophile), 0.06 mmol of tris-
(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3), 0.11
mmol of 1,1-bis(diphenylphosphino)butane (dppb), and 120
mL of anhydrous AN was stirred and boiled under reﬂux for
18−24 h under N2. The solvent was removed by rotary
evaporation. A solution of the residue in 90 mL of
dichloromethane (DCM) was extracted with saturated aq.
NaHCO3 solution (2 × 30 mL) and saturated aq. NaCl
solution (30 mL), dried (Na2SO4), ﬁltered, and evaporated to
dryness. A solution of the crude product in 10 mL of 2 N HCl
in methanol/water was stirred for a few hours, and then, the
solvent was removed by rotary evaporation. The residue was
dried in vacuo (0.1 mm), triturated with diethyl ether (5 × 15
mL) and then again dried in vacuo.
Resynthesis of 2 (CADA·HCl).10 Using the general macro-
cyclization procedure, 1.0 g (1.9 mmol) of 1, which was
prepared as described previously,10 was converted to 1.1 g
(95%) of pure 9-benzyl-3-methylene-1,5-di(p-toluenesulfonyl-
1,5,9-triazacyclododecane hydrochloride (2, CADA·HCl) as a
tan solid.
Resynthesis of 4 (KKD023·HCl).10 Using the general
macrocyclization procedure, 1.0 g (1.8 mmol) of 3, which
was prepared as described previously,10 was converted to 1.0 g
(85%) of pure 9-benzyl-3-methylene-1,5-di(p-methoxybenze-
nesulfonyl-1,5,9-triazacyclododecane hydrochloride 4
(KKD023·HCl) as a tan solid.
Resynthesis of 6 (94-129·HCl).10 Using the general
macrocyclization procedure, 0.82 g (1.9 mmol) of 5, which
was prepared as described previously,36 was converted to 1.0 g
(98%) of pure 3-methylene-1,5-di(p-toluenenesulfonyl-1,5,9-
triazacyclododecane hydrochloride 6 (94-129·HCl) as a tan
solid.
Resynthesis of 8 (ASPB127).10 Using the general macro-
cyclization procedure, 4.2 g (6.3 mmol) of 7, which was
prepared as described previously,10 was converted to 1.46 g
(52%) of pure 9-benzyl-3-methylene-1,5-di(p-bromobenzene-
sulfonyl-1,5,9-triazacyclododecane 8 (ASPB127). In this case,
the triturated HCl salt was converted to the free base by
stirring for several hours with 40 mL of DCM, 40 mL of
saturated aq. NaCl solution, and 50 mL of 2 N aq. KOH
solution. The layers were separated, and the aqueous layer was
extracted with DCM (2 × 25 mL). The combined aqueous
solutions were dried (Na2SO4), ﬁltered, and evaporated to
dryness. The residue was puriﬁed by column chromatography
on alumina, eluting with hexane/ethyl acetate (3:1, v/v).
Resynthesis of 10 (AS114).10 Using the general macro-
cyclization procedure, except for dilution of all reagents and
catalysts to a concentration of 9 mM for the disulfonamide,
0.80 g (1.35 mmol) of 9, which was prepared as described
previously,10 was converted to 0.49 g (56%) of pure 9-benzyl-
3-methylene-1,5-di(p-nitrobenzenesulfonyl-1,5,9-triazacyclodo-
decane 10 (AS114). The free base was generated from the HCl
salt and puriﬁed as described for 8.
Resynthesis of 28 (KKD016·HCl).10 N-(5-Dimethylamino-
naphthalene-1-sulfonyl)-N′-(p-toluenesulfonyl)bis(3-
aminopropyl)cyclohexylmethylamine (27). A mixture of 0.65
g (1.7 mmol) of N-(p-toluenesulfonyl)bis(3-aminopropyl)-
cyclohexylmethylamine, which was prepared as described
previously,11 0.46 g (1.7 mmol) of 5-dimethylaminonaph-
thalene-1-sulfonyl chloride, 11 mL of DCM, 11 mL of
saturated aq. Na2CO3 solution, and 11 mL of saturated aq.
NaCl solution was stirred vigorously at room temperature for
24 h. The layers were separated, and the aqueous layer was
extracted with DCM (2 × 10 mL). The combined organic
solutions were dried (Na2SO4) and concentrated to dryness by
rotary evaporation. The residue was dried in vacuo and
puriﬁed by column chromatography on alumina, eluting with
hexane/EtOAc to give 0.70 g (67%) of 27 as a viscous oil. 1H
NMR (400 MHz, CDCl3) δ 8.52 (d, 9 Hz, 1 H, 2-Dn), 8.33
(d, 9 Hz, 1 H, 4-Dn), 8.22 (d, 7 Hz, 1 H, 8-Dn) 7.71 (d, 8 Hz,
2 H, o-Ts), 7.54 (t, 8 Hz, 1 H, 3-Dn), 7.50 (t, 8 Hz, 1 H, 7-
Dn), 7.26 (d, 8 Hz, 2 H, m-Ts), 7.17 (d, 8 Hz, 1 H, 6-Dn),
6.00 (s, 2 H, NH), 2.94 (m, 4 H, CH2NH), 2.87 (s, 6 H,
NCH3), 2.40 (s, 3 H, ArCH3), 2.26 (m, 4 H, CH2N), 1.98 (d,
7 Hz, 2 H, CH2Cy), 1.61 (t, 8 Hz, 6 H, CCH2C, Cy), 1.52 (m,
4 H, Cy), 1.30 (m, 2 H, Cy), 1.12 (m, 3 H, Cy), 0.74 (m, 2 H,
Cy). 13C (100 MHz, CDCl3) δ 152.0, 143.3, 137.2, 135.2,
130.4, 130.1, 129.9, 129.8, 129.6, 128.4, 127.2, 123.4, 119.3,
115.3, 62.0, 53.2, 53.0, 45.6, 42.8, 42.7, 35.8, 32.0, 26.8, 26.2,
25.9, 21.7. For the synthesis of 27·HCl, a mixture of 0.55 g of
27 in 10 mL of 2 N HCl in methanol/water was stirred at
room temperature for 3 h and then concentrated to dryness by
rotary evaporation. The residue was dried in vacuo and then
triturated with anhydrous diethyl ether (3 × 10 mL) to give
0.57 g (93%) of 27·HCl as a yellowish powder. 1H NMR (500
MHz, CD3OD) δ 8.78 (d, 9 Hz, 1 H, 2-Dn), 8.57 (d, 9 Hz, 1
H, 4-Dn), 8.37 (d, 8 Hz, 1 H, 8-Dn), 7.94 (d, 8 Hz, 1 H, 6-
Dn), 7.85 (m, 2 H, 3,7-Dn), 7.74 (d, 8 Hz, 2 H, o-Ts), 7.41 (d,
8 Hz, 2 H, m-Ts), 3.36 (s, 6 H, NCH3), 3.21 (m, 4 H, CH2N),
2.99 (t, 6 Hz, 2 H, CH2Cy), 2.93 (m, 4 H, CH2NH), 2.44 (s, 3
H, ArCH3), 1.90 (m, 4 H, CCH2C), 1.76 (m, 6 H, Cy), 1.39
(m, 2 H, Cy), 1.25 (m, 1 H, Cy), 1.05 (m, 2 H, Cy). 13C NMR
(125 MHz, CD3OD) δ 145.1, 138.5, 138.1, 131.4, 131.1,
130.8, 129.2, 128.2, 128.0, 127.6, 120.2, 67.0, 61.1, 52.64,
52.56, 47.6, 41.2, 41.1, 34.7, 31.9, 27.0, 26.6, 25.4, 25.1, 24.9,
21.6. Anal. calcd. for C32H46N4O4S2·2HCl: C, 55.88; H, 7.03;
N, 8.15. Found: C, 55.49; H, 7.41; N, 8.07.
Using the general macrocyclization procedure, 0.47 g (0.76
mmol) of 27 was converted to 0.30 g (56%) of pure 9-
cyclohexylmethyl-1-(5-dimethylaminonaphthalenesulfonyl)-3-
methylene-5-(p-toluenesulfonyl)-1,5,9-triazacyclododecane 28
(KKD016·HCl) as a tan solid.
Improved Procedure for Tsuji−Trost Macrocycliza-
tion. Apparatus, reagents, and solvent were dried as described
in the general macrocyclization procedure. In a 250 mL round
bottom ﬂask equipped with a nitrogen inlet and a stirring bar, a
mixture of 6.3 mmol of the disulfonamide, 30 mmol of the
bis(electrophile), 0.76 mmol of anhydrous Na2CO3, 0.37
mmol of tris(dibenzylideneacetone)dipalladium(0)
(Pd2(dba)3), 0.72 mmol of 1,1-bis(diphenyl-phosphino)butane
(dppb), and 730 mL of anhydrous AN was stirred and boiled
under reﬂux for 24 h under nitrogen. The solvent was removed
by rotary evaporation, and the residue was partitioned between
100 mL of saturated aqueous NaHCO3 and 100 mL of
dichloromethane (DCM). The layers were separated, and the
aqueous layer was extracted with DCM (2 × 100 mL). The
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combined organic solutions were concentrated to dryness by
rotary evaporation, and the residue was dried in vacuo. The
products were puriﬁed by column chromatography on neutral
alumina, eluting with hexane/EtOAc.
Synthetic procedures and Characterization Data for
12. A mixture of 0.61 g (2.8 mmol) of N,N-bis(3-
aminopropyl)benzylamine,10 0.88 g (8.3 mmol) of anhydrous
Na2CO3, and 20 mL of anhydrous AN was vigorously stirred
under nitrogen for 10 min at room temperature. A solution of
1.2 g (6.1 mmol) of p-cyanobenzenesulfonyl chloride in 20 mL
of anhydrous AN was added dropwise over 30 min. The
reaction mixture was stirred overnight and ﬁltered. The ﬁltrate
was concentrated to dryness by rotary evaporation, and the
residue was shaken with 50 mL of DCM and 50 mL of
saturated aq. NaCl solution. The layers were separated, and the
aqueous layer was extracted with DCM (2 × 50 mL). The
combined organic solutions were dried and concentrated to
dryness by rotary evaporation. The residue was dried overnight
in vacuo (0.2 mm, 40 °C) to give 1.6 g (100%) of N′,N″-bis(p-
cyanobenzenesulfonyl)[N,N-bis(3-aminopropyl)benzylamine]
(11, ES02) as a viscous oil, which was determined to be
suﬃciently pure for use in the next step. Using the improved
Tsuji−Trost macrocyclization procedure, 1.5 g (2.7 mmol) of
intermediate 11 was converted to 12, which was puriﬁed by
column chromatography on neutral alumina, eluting with 9:1
(v/v) chloroform/ethyl acetate, resulting in 0.82 g (47%) of 9-
benzyl-3-methylene-1,5-bis(p-cyanobenzenesulfonyl)-1,5,9-tri-
azacyclododecane (12, ES03) as ﬁne white crystals, mp 190−
193 °C. 1H NMR (500 MHz, CDCl3) δ 7.90 (d, 9 Hz, 4 H, o-
ArSO2), 7.84 (d, 9 Hz, 4 H, m-ArSO2), 7.25 (m, 3 H, m,p-Ph),
7.13 (m, 2 H, o-Ph ), 5.21 (s, 2 H, CCH), 3.90 (s, 4 H,
H2,4), 3.41 (s, 2 H, CH2Ph), 3.17 (t, 6.7 Hz, 4 H, H6,12),
2.39 (t, 5.8 Hz, 4 H, H8,10), 1.67 (quint., 6 Hz, 4 H, H7,11).
13C NMR (125 MHz, CDCl3) δ 142.8, 137.4, 133.0, 128.7,
127.1, 121.9, 117.1, 116.6, 116.5, 105.2, 59.0, 49.4, 48.0, 44.2,
24.8. MS (ESI+) m/z 604 (MH+). HRMS (ESI-TOF) m/z: [M
+ H]+ calcd. for C31H34N5O4S2 604.2052; found: 604.2046.
Synthetic Procedures and Characterization Data for
30. N′-(p-Acetylbenzenesulfonyl)-N″-(p-toluenesulfonyl)-
[N,N-bis(3-aminopropyl)cyclohexylmethylamine] (29,
DJ004). A mixture of 4.0 g (10.5 mmol) of N-(3-amino-
p r o p y l ) -N - ( 3 - p - t o l u e n e s u l f o n a m i d o p r o p y l ) -
cyclohexylmethylamine,11 2.33 g (10.7 mmol) of p-acetylben-
zenesulfonyl chloride, 69 mL of saturated aq. Na2SO4 solution,
69 mL of saturated aq. NaCl solution, and 69 mL of DCM was
stirred at room temperature for 24 h, then the layers were
separated, and the aqueous layer was extracted with DCM (3 ×
40 mL). The combined organic solutions were dried and
concentrated by rotary evaporation to give a light orange oil. A
solution of the crude product in 140 mL of 2 N HCl in aq.
MeOH was stirred at room temperature for 4 h and then
concentrated to dryness by rotary evaporation. The residue
was dried in vacuo, triturated with anhydrous diethyl ether (3
× 30 mL) and again dried in vacuo to give 3.24 g (87%) of 29·
HCl. A sample was dried overnight in vacuo at 78 °C and
found to be pure (anal. calcd. for C28H42N3O5S2·HCl·0.2H2O:
C, 55.70; H, 7.08; N, 6.96. Found: C, 55.64; H, 6.89; N, 6.89).
The HCl salt was converted back to the free base by stirring
with 185 mL of 2 N aq. NaOH solution, 185 mL of saturated
aq. NaCl solution, and 185 mL of DCM for 5 h. The layers
were separated, and the aqueous phase was extracted with
DCM (2 × 50 mL). The combined organic solutions were
dried and concentrated by rotary evaporation to give a light
yellow oil, which was dried in vacuo to give 2.64 g (78%) of
pure 29 free base. 1H NMR (400 MHz, CDCl3) δ 8.07 (d, 9
Hz, 2 H, o-ArSO2), 7.95 (d, 9 Hz, 2 H, m-ArSO2), 7.72 (d, 8
Hz, 2 H, o-Ts), 7.30 (d, 8 Hz, 2 H, m-Ts), 6.10 (br., 2 H, NH),
3.04 (t, 6 Hz, 2 H, CH2NHSO2At), 2.97 (t, 6 Hz, 2 H,
CH2NHTs), 2.65 (s, 3 H, Ac), 2.43 (s, 3 H, ArCH3), 2.38 (t, 7
Hz, 4 H, CH2NCH2Cy), 2.05 (d, 7 Hz, 2 H, CH2Cy), 1.65 (m,
10 H, CCH2C, Cy), 1.35 (m, 1 H, Cy) 1.14 (m, 2 H, Cy), 0.78
(m, Hz, 2 H, Cy).13C NMR (100 MHz, CDCl3) δ 196.9,
143.7, 143.3, 139.8, 136.5, 129.7, 128.9, 127.4, 127.1, 61.0,
52.3, 41.1, 34.2, 31.6, 26.9, 26.1, 25.6, 21.5. MS (ESI+) m/z
564 (MH+).
1-(p-Acetylbenzenesulfonyl)-9-cyclohexylmethyl-3-meth-
ylene-5-(p-toluenesulfonyl)-1,5,9-triazacyclododecane (30,
DJ005). Using the improved Tsuji−Trost macrocyclization
procedure, intermediate 29 was cyclized to 30, which was
converted to the HCl salt and puriﬁed as described for 29. A
sample of 30·HCl was dried in vacuo at 78 °C and found to be
pure (anal. calcd. for C32H45N3O5S2·HCl·0.2H2O: C, 57.52; H,
7.22; N, 6.27. Found: C, 57.52; H, 7.51; N, 6.12). This sample
of 30·HCl was converted to the free base as described for 29
and isolated by column chromatography on neutral alumina,
eluting with 3:7 (v/v) ethyl acetate/hexane, resulting in 0.41 g
(28%) of a pale yellow solid. 1H NMR (400 MHz, CDCl3) δ
8.08 (d, 9 Hz, 2 H, o-ArSO2), 7.89 (d, 9 Hz, 2 H, m-ArSO2),
7.64 (d, 8 Hz, 2 H, o-Ts), 7.32 (d, 8 Hz, 2 H, m-Ts), 5.15 (s, 2
H, CCH), 3.91 (s, 2 H, H2/4), 3.71 (s, 2 H, H4/2), 3.28 (t,
7 Hz, 2 H, H6/12), 3.04 (t, 7 Hz, 2 H, H12/6), 2.65 (s, 3 H,
Ac), 2.43 (s, 3 H, ArCH3), 2.25 (m, 4 H, H8,10), 1.95 (d, 7
Hz, 2 H, CH2Cy), 1.65 (m, 10 H, H7,11, Cy), 1.13 (m, 3 H,
Cy), 0.73 (m, 2 H, Cy). 13C NMR (100 MHz, CDCl3) δ 196.6,
143.4, 140.5, 139.9, 136.2, 129.7, 129.0, 127.4, 127.1, 61.4,
60.3, 51.9, 51.6, 47.8, 36.0, 31.8, 29.7, 27.7, 26.8, 26.1, 21.5.
MS (ESI+) m/z 616 (MH+).
Synthetic Procedures and Characterization Data for
32. N′-(p-Cyanobenzenesulfonyl)-N″-(p-toluenesulfonyl)-
[N,N-bis(3-aminopropyl)cyclohexylmethylamine (31,
DJ001). A mixture of 3.0 g (7.9 mmol) of N-(3-amino-
p r o p y l ) -N - ( 3 - p - t o l u e n e s u l f o n a m i d o p r o p y l ) -
cyclohexylmethylamine,11 1.6 g (7.9 mmol) of p-cyanobenze-
nesulfonyl chloride, 51 mL of saturated aq. Na2CO3 solution,
51 mL of saturated aq. NaCl solution, and 51 mL of DCM was
stirred at room temperature for 24 h, and then, the layers were
separated. The aqueous layer was extracted with DCM (3 × 30
mL). The combined organic solutions were dried and
concentrated to dryness by rotary evaporation to give a light
orange oil. A solution of the crude product in 103 mL of 2 N
HCl in aq. MeOH was stirred at room temperature for 4 h, and
then, the solvent was removed via rotary evaporation. The
residue was dried in vacuo, triturated with anhydrous diethyl
ether (3 × 20 mL), and again dried in vacuo to give 1.26 g
(28%) of 33·HCl. The HCl salt was converted back to the free
base by stirring with 138 mL of 2 N aq. NaOH solution, 138
mL of saturated aq. NaCl solution, and 138 mL of DCM for 6
h, and then, the layers were separated. The aqueous layer was
extracted with DCM (2 × 50 mL). The combined organic
solutions were dried and concentrated by rotary evaporation to
give a light orange oil that was dried overnight in vacuo to yield
1.09 g (25%) of 31, which was determined to be suﬃciently
pure for conversion to 32. 1H NMR (400 MHz, CDCl3) δ 7.97
(d, 8 Hz, 2 H, o-ArSO2), 7.78 (d, 8 Hz, 2 H, o-Ts), 7.70 (d, 8
Hz, 2 H, m-ArSO2), 7.29 (d, 8 Hz, 2 H, m-Ts), 3.04 (t, 6 Hz, 2
H, CH2NHSO2Ar), 2.96 (t, 6 Hz, 2 H, CH2NHTs), 2.41 (s, 3
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H, CH3), 2.38 (d, 7 Hz, 4 H, CH2NCH2Cy), 2.04 (d, 7 Hz, 2
H, CH2Cy), 1.64 (m, 10 H, CCH2C, Cy), 1.36 (m, 1 H, Cy),
1.12 (m, 2 H, Cy), 0.82 (m, 2 H, Cy). 13C NMR (100 MHz,
CDCl3) δ 144.6, 143.3, 136.8, 132.8, 129.7, 127.7, 127.0,
117.4, 116.0, 62.1, 53.1, 42.7, 42.5, 35.6, 31.9, 26.5, 26.0, 25.8,
21.5. MS (ESI+) m/z 547 (MH+).
1-(p-Cyanobenzenesulfonyl)-9-cyclohexylmethyl-3-meth-
ylene-5-(p-toluenesulfonyl)-1,5,9-triazacyclododecane (32,
DJ002). Using the improved Tsuji−Trost macrocyclization
procedure, intermediate 31 was converted to 32, which was
puriﬁed by column chromatography on neutral alumina,
eluting with 3:7 (v/v) ethyl acetate/hexane, resulting in 0.42
g (36%) of a light orange oil. 1H NMR (400 MHz, CDCl3) δ
7.92 (d, 8 Hz, 2 H, o-ArSO2), 7.81 (d, 8 Hz, 2 H, o-Ts), 7.63
(d, 8 Hz, 2 H, m-ArSO2), 7.32 (d, 8 Hz, 2 H, m-Ts), 5.14 (s, 2
H, CCH), 3.96 (s, 2 H, H2/4), 3.67 (s, 2 H, H4/2), 3.36
(m, 2 H, H6/12), 2.99 (t, 6.3 Hz, 2 H, H12/6), 2.43 (s, 3 H,
CH3), 2.33 (m, 4 H, H8,10), 1.96 (d, 7 Hz, 2 H, CH2Cy), 1.60
(m, 10 H, H7,10, Cy) 1.13 (m, 3 H, Cy), 0.73 (m, 2 H, Cy).
13C NMR (125 MHz, CDCl3) δ 144.0, 143.6, 137.6, 134.4,
133.0, 129.8, 127.7, 127.3, 117.2, 116.5, 116.3, 62.1, 53.0, 50.6,
49.6, 45.3, 43.3, 35.8, 31.9, 27.7, 26.7, 26.0, 25.5, 23.8, 21.5.
MS (ESI+) m/z 599 (MH+). Anal. calcd. for C31H42N4O4S2·
HCl·CH3OH·0.5H2O: C, 56.83; H, 7.15; N, 8.28. Found: C,
56.64; H, 6.82; N, 8.01.
Resynthesis of 48 (CK201·HCl).13 Using the improved
Tsuji−Trost macrocyclization procedure, 0.98 g (1.8 mmol) of
47, which was prepared as described previously,13 was
converted to 0.51 g (47%) of pure 9-benzyl-1-(p-ﬂuorobenze-
nesulfonyl)-3-methylene-5-(p-toluenesulfonyl)-1,5,9-triazacy-
clododecane hydrochloride 48 (CK201·HCl). The chromato-
graphed free base was converted to the HCl salt as described in
the general macrocyclization procedure.
Synthetic Procedures and Characterization Data for
52. N-(3-Hydroxypropyl)-N-(3-p-toluenesulfonamido-
propyl)cyclohexylmethylamine (51, VGD041). A mixture of
4.11 g (12.7 mmol) of N-(3-p-toluenesulfonamidopropyl)-
cyclohexylmethylamine,11 1.48 g (14.0 mmol) of Na2CO3, 0.21
g (1.4 mmol) of NaI, 1.94 g (14.0 mmol) of 3-bromopropan-1-
ol, and 40 mL of AN was stirred under nitrogen, boiled under
reﬂux for 24 h, and then cooled to room temperature. The
resulting white mixture was ﬁltered through a ﬁne-porosity
sintered glass funnel, and the residue was washed with 20 mL
of AN. The combined ﬁltrates were concentrated by rotary
evaporation, and the residue was dried in vacuo to give an oil,
which was puriﬁed by ﬁltration chromatography on neutral
alumina, eluting with 9:1 (v/v) DCM/EtOH followed by neat
EtOH to give 2.30 g (47%) of 51, which was converted to 52
without further puriﬁcation. 1H NMR (500 MHz, CDCl3) δ
7.74 (d, 8 Hz, 2 H, o-Ts), 7.30 (d, 8 Hz, 2 H, m-Ts), 3.73 (t, 6
Hz, 2 H, CH2OH), 2.96 (t, 6 Hz, 2 H, CH2NHTs), 2.54 (t, 6
Hz, 2 H, CH2NCH2Cy), 2.42 (m, 5 H, CH2N, CH3), 2.11 (d,
7 Hz, 2 H, CH2Cy), 1.67 (m, 8 H, CCH2C, Cy), 1.44 (m, 1 H,
Cy), 1.17 (m, 4 H, Cy), 0.82 (m, 2 H, Cy). 13C NMR (125
MHz, CDCl3) δ 143.2, 137.3, 129.7, 127.2, 63.3, 62.1, 54.3,
52.5, 42.1, 35.7, 32.0, 28.2, 26.7, 26.3, 26.1, 21.6. IR (neat,
cm−1): 3280 (w), 2923 (m), 2850 (m), 1598 (w), 1449 (m),
1326 (m), 1159 (s), 1094 (m), 912 (w), 815 (m), 737 (w),
661 (m). HRMS calcd. for C20H34N2O3S (M
+) 382.2285,
found 382.2273; calcd. for C20H34N2O3SNa (M + Na)
+
405.2182, found 405.2184.
N,N′-Bis[(N-cyclohexylmethyl-N-3-hydroxypropyl)-3-ami-
nopropyl]- N,N′-di(p-toluenesulfonyl)-2-methylene-1,3-dia-
minopropane (52, VGD043). A mixture of 0.76 g (2.0
mmol) of 51, 1.42 g (4.93 mmol) of 2-methylene-1,3-
propanebis(t-butylcarbonate), 50 mg (0.12 mmol) of dppb,
57 mg (0.062 mmol) of tris(dibenzylideneacetone)-
dipalladium(0), and 126 mL of anhydrous AN was stirred
under nitrogen and boiled under reﬂux for 24 h, cooled to
room temperature, and concentrated to dryness by rotary
evaporation. A solution of the residue in 95 mL of DCM was
washed with saturated aq. NaHCO3 solution (2 × 30 mL) and
30 mL of saturated aq. NaCl solution, dried (Na2SO4), and
concentrated to dryness by rotary evaporation. Column
chromatography on silica gel, eluting with DCM/MeOH,
gave 0.22 g (27%) of 52 as a light yellow, viscous oil. 1H NMR
(500 MHz, CDCl3) δ 7.69 (d, 8 Hz, 4 H, o-Ts), 7.32 (d, 8 Hz,
4 H, m-Ts), 5.26 (s, 2 H, CCH), 3.78 (m, 8 H, CH2OH,
CH2CC), 3.14 (m, 4 H, CH2NTs), 2.63 (bs, 4 H,
CH2NCH2Cy), 2.43 (s, 10 H, CH3, CH2NCH2Cy), 2.22 (bs,
4 H, CH2Cy), 1.71 (broad, 18 H, CCH2C, Cy), 1.47 (bs, 2 H,
Cy), 1.09 (m, 6 H, Cy), 0.86 (m, 4 H, Cy). 13C NMR (125
MHz, CDCl3) δ 143.7, 140.3, 136.3, 129.9, 127.3, 116.3, 63.4,
61.7, 54.8, 52.0, 51.8, 47.6, 35.4, 31.8, 27.9, 26.6, 26.1, 25.1,
21.6. IR (neat, cm−1): 2923 (m), 2850 (m), 1598 (w), 1449
(m), 1338 (m), 1159 (s), 1091 (m), 1036 (w), 918 (w), 816
(w), 735 (m), 710 (w), 693 (w), 656 (m). A solution of 84 mg
of 52 free base in 10 mL of 2 N HCl in methanol/water was
stirred at room temperature for 4 h and then concentrated to
dryness by rotary evaporation. The residue was dried in vacuo
and then triturated with anhydrous diethyl ether (5 × 20 mL)
using sonication to give 76 mg of 52·2HCl as a cream-colored
solid. 1H NMR (500 MHz, CD3OD) δ 7.76 (d, 8 Hz, 4 H, o-
Ts), 7.46 (d, 8 Hz, 4 H, m-Ts), 5.31 (s, 2 H, CCH), 3.86 (s,
4 H, CCCH2), 3.73 (t, 6 Hz, 4 H, CH2CH2NTs), 3.24 (m,
14 H, CH2NCH2Cy, CH2OH), 3.00 (m, 4 H, CH2Cy), 2.46 (s,
6 H, CH3), 2.02 (m, 4 H, CCH2C), 1.92 (m, 4 H, CCH2C),
1.74 (m, 12 H, Cy), 1.33 (m, 4 H, Cy), 1.22 (m, 2 H, Cy),
1.03 (m, 4 H, Cy). IR (neat, cm−1): 3310 (w), 2925 (m), 2848
(w), 2585 (w), 2487 (w), 1600 (w), 1448 (m), 1331 (s), 1156
(s), 1089 (m), 1060 (m), 1035 (m), 921 (m), 816 (m), 804
(m), 738 (m), 710 (m), 692 (m). MS (ESI+) m/z 817 (MH+).
Anal. calcd. for C44H72N4O6S2·2HCl·0.5H2O: C, 58.78; H,
8.41; N, 6.23. Found: C, 58.62; H, 8.66; N, 6.03.
Resynthesis of 54 (VGD020).11 Using the improved
Tsuji−Trost macrocyclization procedure, 0.21 g (0.38 mmol)
of 53, which was prepared as described previously,11 was
converted to 0.12 g (52%) of pure 9-cyclohexylmethyl-1-(p-
methoxybenzenesulfonyl)-3-methylene-5-(p-toluenesulfonyl)-
1,5,9-triazacyclododecane 54 (VGD020).
Synthetic Procedures and Characterization Data for
56. A mixture of 0.93 g (2.9 mmol) of N-(3-p-
toluenesulfonamidopropyl)benzylamine, 0.60 g (3.0 mmol)
of N-tosylaziridine,37 29 mL of water, and 10 mL of CHCl3
was stirred at 50 °C for 2 h and then allowed to cool to room
temperature. The layers were separated, and the aqueous layer
was extracted with CHCl3 (2 × 25 mL). The combined
organic solutions were concentrated by rotary evaporation, and
the residue was dried in vacuo (50 °C), yielding 1.49 g (99%)
o f N - ( 3 - p - t o l u e n e s u l f o n am i d o p r o p y l ) -N - ( 2 - p -
toluenesulfonamidoethyl)benzylamine (55, ES26) as a light
brown oil, which was suﬃciently pure for use in the next step.
Using the improved Tsuji−Trost macrocyclization procedure,
intermediate 55 was converted to 56, which was puriﬁed by
chromatography on neutral alumina, eluting with 2:3 (v/v)
ethyl acetate/hexane, giving 0.77 g (50%) of 8-benzyl-3-
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methylene-1,5-di(p-toluenesulfonyl)-1,5,8-triazacycloundecane
(56) as a ﬁne beige powder. A sample was converted to the
HCl salt, which was found to be pure by combustion
microanalysis after drying overnight in vacuo at 78 °C. 1H
NMR (500 MHz, CDCl3) δ 7.68 (d, 8 Hz, 2 H, o-Ts), 7.60 (d,
8 Hz, 2 H, o-Ts), 7.33 (d, 8 Hz, 2 H, m-Ts), 7.28 (d, 8 Hz, 2
H, m-Ts), 7.23 (m, 5 H, Ph), 5.43 (s, 1 H, CCH), 5.28 (s, 1
H, CCH), 3.95 (m, 2 H, H2/H4), 3.82 (m, 2 H, H4/H2),
3.50 (s, 2 H, CH2Ph), 3.15 (m, 4 H, H6/11), 2.59 (m, 2 H,
H7), 2.44 (m, 8 H, H9, CH3), 1.87 (m, 2 H, H10).
13C NMR
(125 MHz, CDCl3) δ 143.5, 141.8, 138.0, 129.9, 129.6, 128.3,
127.5, 127.4, 127.1, 116.7, 57.6, 54.0, 53.8, 53.3, 50.4, 48.2,
47.2, 26.8, 21.7. ES-US5·HCl: MS (ESI+) m/z 568 (MH+).
Anal. calcd. for C30H37N3O4S2·HCl: C, 59.64; H, 6.34; N, 6.95.
Found: C, 59.24; H, 6.74; N, 6.84.
Synthetic Procedure and Characterization Data for
58. 6-Methylene-4,8-di(p-toluenesulfonyl)-4,8,15-
triazabicyclo[9,3,1]pentadeca-1(15),11,13-triene (58, SH28).
A mixture of 71 mg (0.15 mmol) of N,N′-di(p-toluenesulfon-
yl)-2,6-bis(2-aminoethyl)pyridine (57),38 104 mg (0.36
mmol) of 2-methylene-1,3-propanediyl bis(t-butylcarbonate),
4 mg (0.11 mmol) of dppb, 2 mg (0.02 mmol) of anhydrous
NaHCO3, 8.5 mL of anhydrous AN, and 4 mg (4 μmol) of
tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3) was
stirred under nitrogen and boiled under reﬂux for 24 h
under nitrogen and then cooled to room temperature. The
solvent was removed by rotary evaporation, and the residue
was stirred with 6 mL of DCM for 30 min and then ﬁltered.
The ﬁltrate was washed with saturated aq. sodium bicarbonate
solution (2 × 2 mL) and saturated aq. sodium chloride
solution (2 x 2 mL) and dried. The ﬁltrate was concentrated by
rotary evaporation to a viscous oil, which was triturated with 2
mL of ether and dried in vacuo to give 69 mg (87%) of a glassy
solid, which was puriﬁed by column chromatography on silica,
eluting with DCM followed by 99:1 (v/v) DCM/CH3OH to
give 44 mg (56%) of 58 as a white solid, mp 194−195 °C. 1H
NMR (500 MHz, CDCl3) δ 7.67 (d, 8 Hz, 4 H, o-Ts), 7.46 (t,
8 Hz, 1 H, H13), 7.33 (d, 8 Hz, 4 H, m-Ts), 6.90 (d, 10 Hz, 2
H, H12,14), 4.87 (s, 2 H, CCH), 3.66 (t, 8 Hz, 4 H, H3,9),
3.34 (s, 4 H, H5,7), 3.05 (t, 8 Hz, 4 H, H2,10), 2.45 (s, 6 H,
CH3).
13C NMR (125 MHz, CDCl3) δ 158.1, 143.5, 137.8,
137.1, 135.5, 129.7, 127.5, 122.4, 52.6, 45.6, 37.3, 21.5. IR
(neat, cm−1): 2919 (w), 2851 (w), 1593 (w), 1574 (w), 1455
(w), 1334 (m), 1309 (m), 1149 (s), 1101 (m), 1087 (m), 915
(m), 813 (m), 760 (m), 687 (m), 580 (s), 549 (s). MS (ESI+)
m/z 526 (MH+, 100%). Anal. calcd. for C27H31N3O4S2: C,
61.69; H, 5.94; N, 7.99. Found: C, 61.48; H, 6.40; N, 7.99.
Synthetic Procedures and Characterization Data for
60. N,N′-Di(p-toluenesulfonyl)-2,6-bis(aminomethyl)-
pyridine (59, LAL009). A mixture of 2.00 g (14.8 mmol) of
pyridine-2,6-dicarboxaldehyde, 4.52 g (26.4 mmol) of p-
toluenesulfonamide, 1.5 mL of triethylamine, and 60 mL of
1,2-dichloroethane was stirred under nitrogen at 0 °C as 11.2 g
(52.8 mmol) of sodium triacetoxyborohydride was added in
portions. The resulting suspension was stirred for 30 min at 0
°C and then at room temperature for 25 h. An additional 5.3 g
(25 mmol) of sodium triacetoxyborohydride and 7 mL of
AcOH were added, and the suspension was stirred for 24 h at
room temperature. The reaction mixture was diluted with 120
mL of EtOAc, 60 mL of distilled water was added, and stirring
was continued for 30 min. After further dilution with 120 mL
of EtOAc, the pH of the aqueous layer was adjusted to 7 with
saturated aq. NaHCO3 solution. The layers were separated,
and the aqueous layer was extracted with EtOAc (2 × 100
mL). The combined organic solutions were washed with
saturated aq. NaHCO3 solution (2 × 100 mL) and then with
saturated aq. NaCl solution (2 × 200 mL), dried (Na2SO4),
and concentrated by rotatory evaporation. Puriﬁcation by
column chromatography on neutral alumina, eluting with 3:7
(v/v) CHCl3/EtOAc, gave 3.42 g (52%) of 59 as a white solid,
mp 115−117 °C. 1H NMR (400 MHz, CDCl3) δ 7.71 (d, 9.2
Hz, 4 H, o-Ts), 7.51 (t, 7.4 Hz, 1 H, p-Py), 7.22 (d, 7.9 Hz, 4
H, m-Ts), 7.03 (d, 7.5 Hz, 2 H, m-Py), 5.66 (s, 2 H, NH), 4.17
(d, 5.8 Hz, 4 H, CH2), 2.39 (s, 6 H, Me).
13C NMR (100
MHz, CDCl3) δ 154.7, 143.5, 137.5, 136.7, 129.7, 127.2, 120.6,
47.4, 21.5. IR (neat, cm−1): 1596 (m), 1461 (w), 1350 (s),
1323 (s), 1155 (s), 1168 (s), 1151 (s), 1087 (s), 1048 (w),
909 (w), 886 (w), 832 (w), 811 (s), 805 (m), 784 (m), 748
(w), 662 (s). MS (ESI+) m/z 469 (MH+ + Na, 100%), 446
(MH+, 28%). Anal. calcd. for C21H23N3O4S2: C, 56.61; H,
5.20; N, 9.43. Found: C, 57.01; H, 5.60; N, 9.83.
5,17-Dimethylene-3,7,15,19-tetrakis(p-toluenesulfonyl)-
3,7,15,19,25,26-hexaazatricyclo[19.3.1.19,13]hexacosa-1-
(25),9(26),10,12,21,23-hexaene (60, LAL012). Using the
improved Tsuji−Trost macrocyclization procedure, 0.50 g
(1.13 mmol) of intermediate 59 was converted to 60, which
was puriﬁed by column chromatography on silica gel, eluting
with 9:1 (v/v) chloroform/ethyl acetate, giving 0.28 g (50%)
of a white solid, mp 213−215 °C (dec). 1H NMR (400 MHz,
CDCl3) δ 7.57 (d, 9 Hz, 8 H, o-Ts), 7.45 (t, 9 Hz, 2 H,
H11,23), 7.25 (m, 8 H, m-Ts), 7.09 (d, 9 Hz, 4 H,
H10,12,22,24), 4.87 (s, 4 H, CCH), 4.07 (s, 8 H,
ArCH2N), 3.70 (s, 8 H, CCCH2N), 2.43 (s, 12 H, Me).
13C NMR (100 MHz, CDCl3) δ 156.2, 143.5, 138.5, 137.2,
136.3, 129.7, 127.4, 121.3, 116.8, 53.2, 51.8, 21.6. IR (neat,
cm−1): 1593 (m), 1445 (w), 1341 (s), 1289 (w), 1155 (s),
1089 (s), 1074 (w), 1060 (w), 992 (w), 968(m), 926 (w), 906
(w), 805 (m), 784 (m), 763 (w), 752 (m), 732 (w), 709 (m),
727 (w), 695 (w), 649 (s), 613 (s), 596 (m). MS (ESI+) m/z
1016 (M−1 + Na+). Anal. calcd. for C50H54N6O8S4: C, 60.34;
H, 5.47; N, 8.44. Found: C, 60.48; H, 5.66; N, 8.53.
Synthetic Procedures and Characterization Data for
62. 2-Carboethoxymethylene-1,3-propanediyl bis(t-butyl-
carbonate) (61).26 A solution of 2.5 g (11 mmol) of triethyl
phosphonoacetate in 150 mL of anhydrous THF was stirred
under nitrogen as 0.81 g (20 mmol) of a 60% dispersion of
NaH in mineral oil was added. The mixture was stirred for 15
min at room temperature and then boiled under reﬂux for 15
min. 2-Oxo-1,3-propane bis(t-butylcarbonate)26 (3.2 g, 11
mmol) was added to the reaction mixture, which was boiled
under reﬂux for 24 h, cooled to room temperature, and
concentrated to a minimum volume by rotary evaporation. A
suspension of the residue in ethyl acetate was ﬁltered, washed
with saturated aq. NaCl solution, and concentrated to dryness
by rotary evaporation. The residue was dried in vacuo and then
puriﬁed by column chromatography on silica gel, eluting with
80:20 (v/v) hexane/ethyl acetate to give 2.8 g (75%) of 61 as a
colorless oil. 1H NMR (400 MHz, CDCl3) δ 6.03 (s, 1 H, C
CH), 5.26 (s, 2 H, CCCH2), 4.74 (s, 2 H, CCCH2), 4.18
(q, 5 Hz, 2 H, OCH2), 1.50 (s, 18 H, t-Bu, 1.29 (t, 5 Hz, 3 H,
CH2CH3).
13C NMR (400 MHz, CDCl3/TMS) δ 167.2,
154.9, 147.6, 117.1, 82.1, 67.1, 65.0, 59.6, 27.6, 14.4.
9-Cyclohexylmethyl-3-(carboethoxymethylene)-1-(p-me-
thoxybenzenesulfonyl)-5-(p-toluenesulfonyl)-1,5,9-triazacy-
clododecane (62, RA014). Using the improved Tsuji−Trost
macrocyclization procedure, N′-(p-methoxybenzenesulfonyl)-
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N″ - (p - to luenesu l fony l ) [N,N - b i s (3 -aminopropy l ) -
cyclohexylmethylamine (53)11 was converted to 62, which was
puriﬁed by column chromatography on neutral alumina,
eluting with 3:1 (v/v) hexane/ethyl acetate, yielding 0.68 g
(30%) of a 1:1 E/Z mixture as a white solid. Recrystallization
from ethyl acetate gave crystals consisting of a 1.4:1 mixture of
stereoisomers. 1H NMR (500 MHz, CDCl3) δ 7.75 (d, 9 Hz,
2.8 H, o-ArSO2, major), 7.70 (d, J = 9 Hz, 2 H, o-ArSO2,
minor), 7.67 (d, 8 Hz, 2 H, o-Ts, minor), 7.61 (d, 8 Hz, 2.8 H,
o-Ts, major), 7.31 (d, 8 Hz, 2 H, m-Ts, minor), 7.26 (d, 8 Hz,
2.8 H, m-Ts, major), 6.98 (d, 9 Hz, 2.8 H, m-ArSO2, major),
6.93 (d, 9 Hz, 2 H, m-ArSO2, minor), 5.29 (s, 2.4 H, CCH,
both), 4.17 (m, 4 H, CH2CH3, both), 3.87 (s, 4.2 H, OCH3,
major), 3.84 (s, 3 H, OCH3, minor), 3.0−3.4 (m, br, 19.2 H,
H2,4,8,10, both), 2.42 (s, 3 H, ArCH3, minor), 2.40 (s, 4.2 H,
ArCH3, major), 2.20 (m, 4.8 H, H6/12, both), 1.92 (m, 4.8 H,
H12/6, both), 1.80 (m, 7.2 H, Cy, both) 1.60 (m, 16.8 H,
H7,11, Cy, both), 1.29 (m, 7.2 H, CH2CH3, both), 1.09 (m,
7.2 H, Cy, both), 0.69 (m, 4.8 H, Cy, both). 13C NMR (125
MHz, CDCl3) δ 170.2, 170.1, 163.0, 162.8, 143.6, 143.2, 135.9,
135.3, 132.7, 132.6, 131.2, 131.1, 130.6, 130.0, 129.7, 129.6,
129.5, 129.4, 127.5, 127.3, 114.2, 114.1, 60.8, 60.6, 55.61,
55.59, 53.4, 52.5, 49.6, 49.0, 45.6, 35.8, 33.2, 32.1, 28.2, 27.5,
26.7, 26.1, 21.6, 21.5, 14.2. IR (neat, cm−1): 2927.6 (w),
2835.8 (w), 2803.9 (w), 1739.1 (m), 1593.0 (m), 1574.9 (w),
1492.9 (w), 1445.6 (w), 1411.8 (w), 1346.4 (s), 1339.2 (s),
1304.4 (m), 1285.9 (w), 1253.8 (w), 1164.6 (s), 1138.9. MS
(ESI+) m/z 676 (MH+). Anal. calcd. for C34H49N3O7S2: C,
60.42; H, 7.31; N, 6.22. Found: C, 60.25; H, 7.49; N, 6.29.
Synthetic Procedures and Characterization Data for
64. 2-Isopropylidene-1,3-propanediyl bis(t-butylcarbonate)
(63, TL001). A mixture of 12.1 g (60.5 mmol) of diethyl 2-
isopropylidenemalonate,39 3.45 g (90.8 mmol) of LiAlH4, and
450 mL of benzene was stirred under nitrogen and boiled
under reﬂux for 6 h and then stirred at 0 °C as 13.5 mL of
deionized water followed by 3.5 mL of 6 N aq. NaOH solution
were added dropwise. The mixture was warmed to room
temperature, stirred for 3 h, and then ﬁltered. The residue was
washed with 1 L of benzene, and then, the combined ﬁltrates
were concentrated to dryness by rotatory evaporation. The
residue was dried in vacuo and then stirred with 200 mL of
diethyl ether, 24.6 g (113 mmol) of di-t-butyl dicarbonate, and
0.55 g (4.5 mmol) of 4-N,N-dimethylaminopyridine. The
resulting solution was stirred for 24 h and then washed with
saturated aq. CuSO4 (3 × 20 mL), saturated aq. NaHCO3 (3 ×
25 mL), and saturated aq. NaCl (3 × 25 mL) solutions. The
solution was dried and concentrated to dryness by rotatory
evaporation. The residue was dried in vacuo and puriﬁed by
column chromatography on silica gel, eluting with 15:85 (v/v)
ethyl acetate/hexane, followed by bulb-to-bulb distillation in
vacuo. This gave 2.2 g (8%) of 63 as a colorless oil. 1H NMR
(400 MHz, CDCl3) δ 4.67 (s, 4 H, CH2), 1.83 (s, 6 H, C
CCH3), 1.47 (s, 18 H, t-Bu).
13C NMR (100 MHz, CDCl3) δ
153.6, 142.3, 122.6, 81.9, 64.7, 27.8, 20.8. IR (neat, cm−1):
2979 (w), 1733 (s), 1456 (w), 1393 (w), 1367 (m), 1269 (m),
1247(s), 1153 (s), 1079 (m), 1035 (w), 927 (w), 854 (m),
792 (m), 764 (w). Anal. calcd. for C16H28O6: C, 60.74; H,
8.92. Found: C, 60.36; H, 8.71.
N,N-B i s [N ′ - ( 3 -methy l - 1 , 3 -bu tad i en -2 - y l ) - 3 -p -
toluenesulfonamidopropyl]cyclohexylmethylamine (64,
TL002). Using the improved Tsuji−Trost macrocyclization
procedure, 80 mg (0.14 mmol) of N′-(p-methoxybenzenesul-
fonyl)-N″-(p-toluenesulfonyl)[N,N-bis(3-aminopropyl)]-
cyclohexylmethylamine (53)11 and 0.20 g (0.69 mmol) of 63
were converted to 64, which was isolated by column
chromatography on neutral alumina, eluting with 4:1
hexane/ethyl acetate to give 66.1 mg (88%) of 64 as a viscous
yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.74 (d, 9 Hz, 2 H,
o-ArSO2), 7.69 (d, 8 Hz, 2 H, o-Ts), 7.30 (d, 8 Hz, 2 H, m-Ts),
6.97 (d, 9 Hz, 2 H, m-ArSO2), 5.26 (s, 2 H, CCH), 5.24 (s,
2 H, CCH), 5.15 (s, 2 H, CCH), 5.07 (s, 2 H, CCH),
3.92 (s, 3 H, OCH3), 3.87 (m, 4 H, CCCH2NSO2), 3.02
(m, 4 H, CH2CH2NSO2), 2.42 (s, 3 H, ArCH3), 2.17 (t, 7 Hz,
4 H, CH2NCH2Cy), 1.95 (d, 7.1 Hz, 2 H, CH2Cy), 1.91 (s, 6
H, CCCH3), 1.64 (m, 10 H, CCH2C, Cy), 1.19 (m, 3 H,
Cy), 0.72 (m, 2 H, Cy). 13C NMR (125 MHz, CDCl3) δ 162.7,
143.1, 142.4, 142.3, 140.4, 136.3, 131.0, 129.6, 129.3, 127.2,
115.7, 115.6, 114.41, 114.39, 114.1, 61.3, 61.2, 55.5, 52.1, 52.0,
51.71, 51.68, 47.03, 47.00, 36.0, 31.8, 27.7, 26.9, 26.2, 26.1,
21.5, 21.3. HRMS (ESI-TOF) m/z: [M + H]+ calcd. for
C39H58N3O5S2 712.3818; found 712.3788.
Synthetic Procedures and Characterization Data for
66. 2-Benzylidene-1,3-propanediyl bis(t-butylcarbonate)
(65, TL004). A mixture of 1.50 g (9.14 mmol) of 2-
benzylidenepropane-1,3-diol,40 0.11 g (0.91 mmol) of 4-N,N-
dimethylaminopyridine, 4.18 g (19.2 mmol) of di-t-butyl
dicarbonate, and 100 mL of diethyl ether was stirred at room
temperature under nitrogen for 24 h. The resulting solution
was washed with saturated aq. CuSO4 (3 × 20 mL), saturated
aq. NaHCO3 (3 × 20 mL), and saturated aq. NaCl (3 × 20
mL) solutions, dried, and concentrated to dryness by rotary
evaporation. The residue was dried in vacuo and puriﬁed by
column chromatography on silica gel, eluting with 1:15 (v/v)
ethyl acetate/hexane, giving 3.1 g (94%) of 65 as a viscous
clear oil. 1H NMR (400 MHz, CDCl3) δ 7.34 (m, 2 H, o-Ph),
7.27 (m, 3 H, m,p-Ph), 6.85 (s, 1 H, CCH), 4.76 (s, 2 H,
CH2), 4.74 (s, 2 H, CH2), 1.49 (s, 9 H, t-Bu), 1.46 (s, 9 H, t-
Bu). 13C NMR (100 MHz, CDCl3) δ 153.3, 153.2, 135.3,
134.9, 130.5, 128.8, 128.4, 127.8, 82.3, 68.6, 62.9, 27.76, 27.74.
IR (neat cm−1) 2979 (w), 1736 (s), 1457 (w), 1394 (w), 1367
(m), 1270 (s), 1246 (s), 1151 (s), 1083 (m), 1035 (w), 925
(w), 896 (m), 855 (m), 790 (w), 765 (m), 752 (w), 729 (m),
698 (m), 619 (m), 595 (w), 591 (w). MS (ESI+) m/z 387 (M
+ Na+). Anal. calcd. for C20H28O6: C, 65.92; H, 7.74. Found:
C, 65.82; H, 7.66.
9-Benzyl-3-benzylidene-1,5-di(p-toluenesulfonyl)-1,5,9-
triazacyclododecane (66, TL005). Using the improved Tsuji−
Trost macrocyclization procedure, 0.15 g (0.29 mmol) of
N′ ,N″-di(p-toluenesulfonyl)-N ,N-bis(3-aminopropyl)-
benzylamine and 0.50 g (1.37 mmol) of 65 were converted to
66, which was puriﬁed by column chromatography on neutral
alumina, eluting with 1:4 (v/v) ethyl acetate/hexane, and 82
mg (47%) of the HCl salt was isolated as a white solid, mp
58−67 °C. 1H NMR (500 MHz, CDCl3) δ 7.73 (d, 8 Hz, 2 H,
o-Ts), 7.55 (d, 8 Hz, 2 H, o-Ts), 7.29 (m, 4 H, m-Ts), 7.23 (m,
5 H, Ph), 7.15 (m, 2 H, Ph), 7.12 (m, 3 H, Ph), 6.80 (s, 1 H,
CCH), 4.27 (s, 2 H, CH2CC), 3.86 (s, 2 H, CH2CC),
3.49 (m, 2 H, H6/12), 3.40 (s, 2 H, CH2Ph), 2.74 (m, 2 H,
H12/6), 2.53 (m, 2 H, H8/10), 2.43 (s, 3 H, ArCH3), 2.41 (s,
3 H, ArCH3), 2.28 (s, 2 H, H10/8), 1.81 (m, 2 H, H7/11),
1.47 (m, 2 H, H11/7). 13C NMR (100 MHz, CDCl3) δ 143.7,
143.1, 139.5, 138.0, 136.0, 133.5, 130.9, 129.8, 128.9, 128.3,
127.5, 127.0, 59.5, 50.4, 49.6, 48.7, 47.6, 47.2, 42.6, 26.6, 22.6,
21.5. IR (neat, cm−1): 3057 (w), 3027 (w), 2923 (w),
2236(w), 1712 (w), 1597 (w), 1493 (w), 1452 (w), 1377 (w),
1337 (m), 1160 (s), 1088 (m), 1017 (w), 993 (w), 925 (w),
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814 (w), 746 (m) 724 (m), 699 (s), 657 (m). MS (ESI+) m/z
658 (MH+). Anal. calcd. for C37H44O4S2·HCl: C, 64.00; H,
6.39; N, 6.05. Found: C, 64.26; H, 6.66; N, 5.67.
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